In the country – answer the answer ‘risk group 608’ did not receive the booster vaccine What type of antidote should the doctor prescribe?

Thursday, 19 January 2023, 10.52 am

Answer the answer ‘risk group 608’ did not receive the booster vaccine. What type of antidote should the doctor prescribe?

January 19, 2023, MD Manoon Leechawengwong, head of the ICU specializing in respiratory diseases, intensive care unit and geriatric diseases. at Vichaiyut Hospital Post a message via Facebook “Mr. Manoon Leechawengwong FC” with the following content…

“The 608 risk group, especially those who have not yet received the COVID-19 booster vaccine. when infected with the covid virus doctors should prescribe a highly effective antiviral drug, oral Paxlovid. or remdesivir injection Molnupiravir should not be given because molnupiravir is not as effective at preventing serious illness or death as Paxlovid or Remdesivir.

In addition, people face a very high risk of serious illness. Or there is a chance that the COVID virus will remain in the body (persistent) for a long time, making it sick again. For example, very old people have many congenital diseases ​​​​​​and have never received one dose of vaccine. or if you have lymphoma, are receiving chemotherapy and people who have had complete chemotherapy If possible, it is advisable to give 2 antiretroviral drugs, Paxlovid and Remdesivir together (dual) promptly, because the either drug as effective as the 2 drugs at the same time Some people can be supplemented with Evusheld ready immune therapy from the beginning,. you must hurry to use Evusheld completely because in the future, when the new mutant XBB virus enters Thailand, Evusheld cannot be used to prevent and treat the XBB virus.

A 69-year-old woman with lymphoma. I just received my first chemotherapy. Received 2 doses of Astra vaccine and 1 dose of Pfizer, body aches, low grade fever 1 day, positive ATK, normal oxygen levels. normal lung x-ray

Remdesivir and paxlovid injection were given together for 5 days and Evwsheld was given intramuscularly on day 1 on the first day. Patients can take the drug without side effects. Stayed in hospital for 5 days, recovered, chest x-rays before returning home normal, followed up 2 weeks after the onset of the COVID-19 infection, no symptoms, allowed to continue receiving chemotherapy on for lymphoma treatment”


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.